When did Ocular Therapeutix report Q4 2024 earnings?

Ocular Therapeutix (OCUL) reported Q4 2024 earnings on March 3, 2025 before market open.

What were Ocular Therapeutix's Q4 2024 revenue and EPS?

Ocular Therapeutix reported revenue of $17.1M and eps of $-0.29 for Q4 2024.

Did Ocular Therapeutix beat estimates in Q4 2024?

Revenue missed the consensus estimate of $17.1M by $29.8K. EPS missed the consensus estimate of $-0.24 by $0.05.

Where can I find Ocular Therapeutix's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-002000) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ocular Therapeutix OCUL Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

Revenue$17.1MMiss by $29.8K

EPS-$0.29Miss by $0.05

Revenue estimate$17.1M

EPS estimate-$0.24

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$13.2M

EPS estimate-$0.40

Financials

Q4 2024

Income statement

See full

Revenue$17.1M+15.4%

Gross profit$15.9M+18.2%

Operating income-$50.6M-152%

Net income-$48.4M-65.6%

EPS (diluted)-$0.28-12.0%

Balance sheet

See full

Cash & equivalents$392.1M+100%

Total debt$75.8M+2.1%

Total equity$315.3M+246%

Total assets$457.9M+81.7%

Cash flow

See full

Operating cash flow-$39.4M-75.6%

CapEx$202.0K-56.0%

Free cash flow-$39.6M-73.0%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.34B+257%

Enterprise value$1.03B+302%

P/S21.1×+14.6×

Profitability

See full

Gross margin91.2%+0.2pp

Operating margin-269.6%+2,807pp

Net margin-303.7%-1,836pp

FCF margin-213.4%+369pp

Returns & leverage

See full

Return on equity-95.2%-19.3pp

Debt / equity0.2×-0.6×

Current ratio10.7×+4.0×

Segments

By segment

See full

Single Reportable$17.1M+16.9%

Versus estimates

Revenue

Q1 2026$10.8MMiss by $1.9M Q4 2025$13.3MMiss by $2.9M Q3 2025$14.5MMiss by $1.6M Q2 2025$13.5MMiss by $1.1M Q1 2025$10.6MMiss by $2.5M

Q4 2024$17.1MMiss by $29.8K

Diluted EPS

Q1 2026-$0.41Miss by $0.09 Q4 2025-$0.29Beat by $0.04 Q3 2025-$0.37Beat by $0.02 Q2 2025-$0.39Miss by $0.04 Q1 2025-$0.37Miss by $0.08

Q4 2024-$0.29Miss by $0.05

Ask the moment Ocular Therapeutix reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Ocular Therapeutix report Q4 2024 earnings?: Ocular Therapeutix (OCUL) reported Q4 2024 earnings on March 3, 2025 before market open.
What were Ocular Therapeutix's Q4 2024 revenue and EPS?: Ocular Therapeutix reported revenue of $17.1M and eps of $-0.29 for Q4 2024.
Did Ocular Therapeutix beat estimates in Q4 2024?: Revenue missed the consensus estimate of $17.1M by $29.8K. EPS missed the consensus estimate of $-0.24 by $0.05.
Where can I find Ocular Therapeutix's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-002000) directly on SEC EDGAR. The filing index links above go to sec.gov.